Micron Biomedical is pioneering a needle-free, thermostable delivery system for vaccines and therapeutics through its innovative dissolvable microarray technology. This approach allows for the self-administration of medications by simply applying a microarray to the skin and pressing a button, enabling painless delivery within seconds to minutes. The technology is designed to overcome significant logistical barriers associated with traditional vaccine and drug administration, such as the need for refrigeration, trained healthcare personnel, and the disposal of sharps waste. By making the process accessible and user-friendly, Micron aims to enhance patient compliance and address vaccine hesitancy.

The microarray technology is not only painless but also versatile, capable of delivering a wide range of active and inactive compounds. Micron's proprietary formulation ensures that the therapeutics remain stable at room temperature, thereby reducing or eliminating the cold chain requirements typically necessary for vaccine storage and transport. This innovation has the potential to significantly lower shipping costs and expand access to life-saving medications in various settings, including at home or in remote areas. By integrating the appropriate doses directly into the microarray, Micron also eliminates the need for vials and reconstitution, further minimizing medical waste and simplifying the logistics of pharmaceutical delivery.

United States

Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid
path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed.
This technology is designed to increase patient access to drugs and vaccines that would
otherwise require expert injection and to improve safety and efficacy by skin targeting.

Micron Biomedical

Company Details